文献速递炎症性肠病

炎症性肠病患者胃肠道患者报告结局测量信息系统(GI-PROMIS)症状量表的评估

Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.
PubMed 文献 · Am J Gastroenterol · 2017-08-29

研究基于美国克罗恩病与结肠炎基金会互联网队列,纳入2378例克罗恩病和1455例溃疡性结肠炎患者,评估8个GI-PROMIS症状域与疾病活动度和生活质量指数的关联。结果显示,在有胃肠道症状的炎症性肠病患者中,GI-PROMIS各域与疾病活动度和生活质量指数强相关,具有作为患者报告结局测量工具的潜力。

要点

  • 在有症状的克罗恩病患者中,活动期患者全部8个GI-PROMIS症状域评分均显著差于缓解期患者。
  • 在有症状的溃疡性结肠炎患者中,除吞咽困难域外,活动期患者其余7个症状域评分显著差于缓解期患者。
  • 生活质量较差的炎症性肠病患者全部8个GI-PROMIS症状域评分均显著差于生活质量较好者。

核心结论

  • 在有胃肠道症状的炎症性肠病患者中,GI-PROMIS各域与疾病活动度和生活质量指数强相关。
  • GI-PROMIS有潜力作为炎症性肠病的患者报告结局测量工具,并与该人群中其他经验证的指数相关。

研究设计与样本

  • 研究为嵌套于美国克罗恩病与结肠炎基金会Partners互联网炎症性肠病队列的横断面研究。
  • 研究纳入2378例克罗恩病和1455例溃疡性结肠炎受访者,中位年龄41岁。
  • 克罗恩病中位病程11年,溃疡性结肠炎中位病程8年;57%的克罗恩病患者和42%的溃疡性结肠炎患者处于缓解期。
  • 研究采用单变量和双变量分析评估8个GI-PROMIS域(反流、吞咽、腹泻、恶心、腹痛、排气、失禁和便秘)与生活质量和疾病活动度指数的关联。

主要发现

  • 在有症状的克罗恩病患者中,活动期患者全部8个GI-PROMIS域的症状评分均显著差于缓解期患者。
  • 在有症状的溃疡性结肠炎患者中,除吞咽困难域外,活动期患者其余7个域的症状评分显著差于缓解期患者。
  • 生活质量较差的炎症性肠病患者全部8个GI-PROMIS域的症状评分均显著差于生活质量较好者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patient reported outcomes (PROs) are important treatment endpoints in inflammatory bowel diseases (IBD). We evaluated the gastrointestinal (GI) PRO Measurement Information System (PROMIS) in IBD subjects. METHODS: Crohn's and Colitis Foundation of America's Partners is an Internet-based cohort of IBD subjects. Participants complete surveys, including demographics, disease characteristics, PROMIS domains, disease activity (short Crohn's disease activity index or simple clinical colitis activity index) and quality of life (QoL) indices. In a nested cross-sectional study, we used univariate and bivariate analyses to assess associations between 8 GI-PROMIS domains (reflux, swallowing, diarrhea, nausea, belly pain, gas, incontinence, and constipation) and QoL and disease activity indices. RESULTS: The study included 2,378 Crohn's Disease (CD) and 1,455 ulcerative colitis (UC) respondents with a median age of 41 years. Median disease duration was 11 years for CD subjects and 8 years for UC subjects; 57% of CD subjects and 42% of UC subjects were in remission. Among symptomatic CD subjects, those with active CD reported significantly worse symptoms on all 8 domains than those in remission. The same was observed for UC subjects with the exception of disrupted swallowing. IBD subjects with worse QoL reported significantly worse symptoms on all 8 domains compared to those with better QoL. CONCLUSIONS: In IBD subjects experiencing GI symptoms, GI-PROMIS domains were strongly associated with disease activity and QoL indices. GI-PROMIS holds potential as PRO measures in IBD and correlates with other validated indices in this population.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kochar B, Martin CF, Kappelman MD, et al. Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases. Am J Gastroenterol. 2017. PMID: 28853727. doi:10.1038/ajg.2017.240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。